238 related articles for article (PubMed ID: 20697836)
1. Intensive versus conventional insulin therapy in critically ill neurologic patients.
Green DM; O'Phelan KH; Bassin SL; Chang CW; Stern TS; Asai SM
Neurocrit Care; 2010 Dec; 13(3):299-306. PubMed ID: 20697836
[TBL] [Abstract][Full Text] [Related]
2. Intensive insulin therapy in the neurocritical care setting is associated with poor clinical outcomes.
Graffagnino C; Gurram AR; Kolls B; Olson DM
Neurocrit Care; 2010 Dec; 13(3):307-12. PubMed ID: 21086066
[TBL] [Abstract][Full Text] [Related]
3. Optimal glycemic control in neurocritical care patients: a systematic review and meta-analysis.
Kramer AH; Roberts DJ; Zygun DA
Crit Care; 2012 Oct; 16(5):R203. PubMed ID: 23082798
[TBL] [Abstract][Full Text] [Related]
4. Assessing glycemic variability in critically ill patients: A prospective cohort study comparing insulin infusion therapy with insulin sliding scale.
Almagthali A; Alsohimi S; Alkhalaf A; Al Sulaiman K; Aljuhani O
Sci Rep; 2024 May; 14(1):10128. PubMed ID: 38698018
[TBL] [Abstract][Full Text] [Related]
5. Intensive insulin therapy after severe traumatic brain injury: a randomized clinical trial.
Bilotta F; Caramia R; Cernak I; Paoloni FP; Doronzio A; Cuzzone V; Santoro A; Rosa G
Neurocrit Care; 2008; 9(2):159-66. PubMed ID: 18373223
[TBL] [Abstract][Full Text] [Related]
6. Intensive versus conventional insulin therapy in critically ill neurologic patients: still searching for the sweet spot.
Frontera JA
Neurocrit Care; 2010 Dec; 13(3):295-8. PubMed ID: 20972647
[No Abstract] [Full Text] [Related]
7. [The optimal blood glucose target in critically ill patient: comparison of two intensive insulin therapy protocols].
Raurell Torredà M; del Llano Serrano C; Almirall Solsona D; Catalan Ibars RM; Nicolás Arfelis JM
Med Clin (Barc); 2014 Mar; 142(5):192-9. PubMed ID: 23490488
[TBL] [Abstract][Full Text] [Related]
8. The glucoregulatory benefits of glucagon-like peptide-1 (7-36) amide infusion during intensive insulin therapy in critically ill surgical patients: a pilot study.
Galiatsatos P; Gibson BR; Rabiee A; Carlson O; Egan JM; Shannon RP; Andersen DK; Elahi D
Crit Care Med; 2014 Mar; 42(3):638-45. PubMed ID: 24247476
[TBL] [Abstract][Full Text] [Related]
9. Intensive insulin therapy in severe traumatic brain injury: a randomized trial.
Coester A; Neumann CR; Schmidt MI
J Trauma; 2010 Apr; 68(4):904-11. PubMed ID: 20032790
[TBL] [Abstract][Full Text] [Related]
10. Glucose control in the intensive care unit.
Fahy BG; Sheehy AM; Coursin DB
Crit Care Med; 2009 May; 37(5):1769-76. PubMed ID: 19325461
[TBL] [Abstract][Full Text] [Related]
11. Intensive versus conventional glucose control in critically ill patients.
; Finfer S; Chittock DR; Su SY; Blair D; Foster D; Dhingra V; Bellomo R; Cook D; Dodek P; Henderson WR; Hébert PC; Heritier S; Heyland DK; McArthur C; McDonald E; Mitchell I; Myburgh JA; Norton R; Potter J; Robinson BG; Ronco JJ
N Engl J Med; 2009 Mar; 360(13):1283-97. PubMed ID: 19318384
[TBL] [Abstract][Full Text] [Related]
12. Intravenous insulin therapy in the maintenance of strict glycemic control in nondiabetic acute stroke patients with mild hyperglycemia.
Staszewski J; Brodacki B; Kotowicz J; Stepien A
J Stroke Cerebrovasc Dis; 2011; 20(2):150-4. PubMed ID: 20621520
[TBL] [Abstract][Full Text] [Related]
13. Effect of intensive insulin therapy on insulin sensitivity in the critically ill.
Langouche L; Vander Perre S; Wouters PJ; D'Hoore A; Hansen TK; Van den Berghe G
J Clin Endocrinol Metab; 2007 Oct; 92(10):3890-7. PubMed ID: 17666481
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of intensive insulin therapy for critically ill neurologic patients: a meta-analysis.
Shan L; Hao PP; Chen YG
J Trauma; 2011 Nov; 71(5):1460-4. PubMed ID: 22071938
[TBL] [Abstract][Full Text] [Related]
15. Intensive insulin therapy in critically ill hospitalized patients: making it safe and effective.
Klonoff DC
J Diabetes Sci Technol; 2011 May; 5(3):755-67. PubMed ID: 21722591
[TBL] [Abstract][Full Text] [Related]
16. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control.
Grey NJ; Perdrizet GA
Endocr Pract; 2004; 10 Suppl 2():46-52. PubMed ID: 15251640
[TBL] [Abstract][Full Text] [Related]
17. Treating hyperglycemia in neurocritical patients: benefits and perils.
Godoy DA; Di Napoli M; Rabinstein AA
Neurocrit Care; 2010 Dec; 13(3):425-38. PubMed ID: 20652767
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Basal Plus Versus Sliding Scale Insulin Therapy on Glucose Variability in Critically Ill Patients Without Preexisting Diabetes.
Webster RE; Belfer JJ; Schmidt KJ
Ann Pharmacother; 2024 Jun; 58(6):565-571. PubMed ID: 37700565
[TBL] [Abstract][Full Text] [Related]
19. Glycemic variability and mortality in critically ill patients: the impact of diabetes.
Krinsley JS
J Diabetes Sci Technol; 2009 Nov; 3(6):1292-301. PubMed ID: 20144383
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial of hyperglycemic control in pediatric intensive care.
Macrae D; Grieve R; Allen E; Sadique Z; Morris K; Pappachan J; Parslow R; Tasker RC; Elbourne D;
N Engl J Med; 2014 Jan; 370(2):107-18. PubMed ID: 24401049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
